(Q36499222)

14 August 2017

1 reference

title

Therapeutic aspects of chaperones/heat-shock proteins in neuro-oncology (English)

1 reference

14 August 2017

0 references

2

Darell D Bigner

1 reference

14 August 2017

Michael W Graner

1

1 reference

14 August 2017

publication date

1 May 2006

1 reference

Expert Review of Anticancer Therapy

14 August 2017

published in

1 reference

14 August 2017

volume

6

1 reference

14 August 2017

issue

5

1 reference

14 August 2017

page(s)

679-695

1 reference

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Small heat shock proteins HSP27 and alphaB-crystallin: cytoprotective and oncogenic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

The Stress Response: Implications for the Clinical Development of Hsp90 Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

The glucose-regulated proteins: stress induction and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Role of the heat shock response and molecular chaperones in oncogenesis and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Stress proteins and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Macromolecular crowding: obvious but underappreciated

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Some like it hot: the structure and function of small heat-shock proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Novel insights into the mechanism of chaperone-assisted protein disaggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Hsp70 chaperones: cellular functions and molecular mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Functional specificity of co-chaperone interactions with Hsp90 client proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

21 January 2018

Heat shock protein 90.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Folding of newly translated proteins in vivo: the role of molecular chaperones

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Chaperone proteins and brain tumors: potential targets and possible therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Expression of alpha B-crystallin in human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Expression analysis of mortalin, a unique member of the Hsp70 family of proteins, in rat tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Elevated levels of mortalin expression in human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Presence of molecular chaperones, heat shock cognate (Hsc) 70 and heat shock proteins (Hsp) 40, in the postsynaptic structures of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Association of heat shock proteins and neuronal membrane components with lipid rafts from the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

The distribution and localization of hsp110 in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Widespread constitutive expression of HSP90 messenger RNA in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Constitutive expression of heat shock protein HSP25 in the central nervous system of the developing and adult mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Roles of molecular chaperones in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Identification of cerebral neurons and glial cell types inducing heat shock protein Hsp70 following heat stress in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

In vitro studies show that Hsp70 can be released by glia and that exogenous Hsp70 can enhance neuronal stress tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Release of heat shock proteins (Hsps) and the effects of extracellular Hsps on neural cells and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Identification of differentially expressed proteins in human glioblastoma cell lines and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Molecular classification and survival prediction in human gliomas based on proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Proteomic studies on low- and high-grade human brain astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Molecular chaperones and the stress of oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Escaping cell death: survival proteins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Heat shock proteins: endogenous modulators of apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

HSP27 and HSP70: potentially oncogenic apoptosis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Downstream caspases are novel targets for the antiapoptotic activity of the molecular chaperone hsp70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Ectopic expression of Hsp70 confers resistance and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

HSP90 and the chaperoning of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Hsp90 as a capacitor for morphological evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Hsp90 as a capacitor of phenotypic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Under cover: causes, effects and implications of Hsp90-mediated genetic capacitance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Cancer. Addiction to oncogenes--the Achilles heal of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

New insight into oncoprotein-targeted antitumor effect: herbimycin A as an antagonist of protein tyrosine kinase against Ph1-positive leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Geldanamycin-induced destabilization of Raf-1 involves the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Therapeutic and diagnostic implications of Hsp90 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Altered states: selectively drugging the Hsp90 cancer chaperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Geldanamycin inhibits migration of glioma cells in vitro: a potential role for hypoxia-inducible factor (HIF-1alpha) in glioma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Interaction of Hsp90 with the nascent form of the mutant epidermal growth factor receptor EGFRvIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Medulloblastoma Sensitivity to 17-Allylamino-17-demethoxygeldanamycin Requires MEK/ERK

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Enhanced tumor cell radiosensitivity and abrogation of G2 and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Synergistic interaction between 17-AAG and phosphatidylinositol 3-kinase inhibition in human malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

The Clinical Applications of Heat Shock Protein Inhibitors in Cancer - Present and Future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Herceptin-geldanamycin immunoconjugates: pharmacokinetics, biodistribution, and enhanced antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Monoclonal antibodies for brain tumour treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Development of small molecule Hsp90 inhibitors: utilizing both forward and reverse chemical genomics for drug identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Design, synthesis, and biological evaluation of HSP90 inhibitors based on conformational analysis of radicicol and its analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics - an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Clinical immunotherapy for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Tumor immunology, immunomics and targeted immunotherapy for central nervous system malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Heat shock proteins and their use as anticancer vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Immunotherapy for human cancer using heat shock protein-peptide complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Chaperone-rich cell lysates, immune activation and tumor vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Tumor rejection antigens of chemically induced sarcomas of inbred mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

A mouse tumor-specific transplantation antigen is a heat shock-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Heat shock proteins transfer peptides during antigen processing and CTL priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Cancer immunotherapy and heat-shock proteins: promises and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Current ideas about applications of heat shock proteins in vaccine design and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Immunopotentiating heat shock proteins: negotiators between innate danger and control of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Facets of heat shock protein 70 show immunotherapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Immunological aspects of heat-shock proteins-the optimum stress of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Novel heat shock protein Hsp70L1 activates dendritic cells and acts as a Th1 polarizing adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Activation of natural killer cells by heat shock protein 70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Cell surface-bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by specific binding and uptake of granzyme B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: protection against radiation-induced effects and target structure for natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Immune responses to stress proteins: applications to infectious disease and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Endogenous extra-cellular heat shock protein 72: releasing signal(s) and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

A fresh look at tumor immunosurveillance and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Hsc70 and Hsp70 interact with phosphatidylserine on the surface of PC12 cells resulting in a decrease of viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Heat shock protein-70 expressed on the surface of cancer cells binds parathyroid hormone-related protein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Surface expression of Hsp25 and Hsp72 differentially regulates tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Silencing the hsp25 gene eliminates migration capability of the highly metastatic murine 4T1 breast adenocarcinoma cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Hsp27: novel regulator of intracellular redox state

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Expression of the molecular chaperone Hsp70 in detergent-resistant microdomains correlates with its membrane delivery and release

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Re-setting the biologic rationale for thermal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

How do cells respond to their thermal environment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Thermal regulation of lymphocyte trafficking: hot spots of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Role of HSPs and telomerase in radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Inhibiting induction of heat shock proteins as a strategy to enhance cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Differential effects of Hsp90 inhibition on protein kinases regulating signal transduction pathways required for myoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Morphological changes and stress responses in neurons in cerebral cortex infiltrated by diffuse astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Immunotherapy for human glioma: innovative approaches and recent results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Reversal of tumor-induced immunosuppression by TGF-beta inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Revival of the regulatory T cell: new targets for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Development of Purine-Scaffold Small Molecule Inhibitors of Hsp90

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Leveraging the activity of tumor vaccines with cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Combining cytotoxic and immune-mediated gene therapy to treat brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

Peptide-binding specificity of the molecular chaperone BiP

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.5.679

21 January 2018

Identifiers

DOI

10.1586/14737140.6.5.679

1 reference

14 August 2017

1 reference